|
|
Volumn 18, Issue 1, 2012, Pages 7-
|
|
Next-generation proteasome blockers promise safer cancer therapy.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BORON DERIVATIVE;
CARFILZOMIB;
CYSTEINE PROTEINASE INHIBITOR;
DRUG DERIVATIVE;
GLYCINE;
MLN 9708;
OLIGOPEPTIDE;
PROTEASOME;
CLINICAL TRIAL (TOPIC);
DRUG ANTAGONISM;
DRUG APPROVAL;
DRUG INDUSTRY;
ECONOMICS;
HUMAN;
NEOPLASM;
NOTE;
ANTINEOPLASTIC AGENTS;
BORON COMPOUNDS;
CLINICAL TRIALS AS TOPIC;
CYSTEINE PROTEINASE INHIBITORS;
DRUG APPROVAL;
DRUG INDUSTRY;
GLYCINE;
HUMANS;
NEOPLASMS;
OLIGOPEPTIDES;
PROTEASOME ENDOPEPTIDASE COMPLEX;
|
|
EID: 84858321881
PISSN: 1546170X
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0112-7a Document Type: Note |
|
Times cited : (12)
|
|
References (0)
|
